Literature DB >> 21763468

Autoimmunity in 2010.

Carlo Selmi1.   

Abstract

There is now growing evidence that autoimmunity is the common trait connecting multiple clinical phenotypes albeit differences in tissue specificity, pathogenetic mechanisms, and therapeutic approaches cannot be overlooked. Over the past years we witnessed a constant growth of the number of publications related to autoimmune diseases in peer-reviewed journals of the immunology area. Original data referred to factors from common injury pathways (i.e. T helper 17 cells, serum autoantibodies, or vitamin D) and specific diseases such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. As an example, the issue of a latitudinal gradient in the prevalence and incidence rates has been proposed for all autoimmune diseases and was recently coined as geoepidemiology to suggest new environmental triggers for tolerance breakdown. The present article is aimed at reviewing the articles that were published over the past year in the major autoimmunity and immunology journals.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763468     DOI: 10.1016/j.autrev.2011.06.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

Review 1.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

2.  Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.

Authors:  Gabriela Dumitrescu; Catalina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

4.  The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Authors:  Balázs Szalay; Barna Vásárhelyi; Aron Cseh; Tivadar Tulassay; Magdolna Deák; László Kovács; Attila Balog
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

5.  Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells.

Authors:  A Mastrofrancesco; M Alfè; E Rosato; V Gargiulo; C Beatrice; G Di Blasio; B Zhang; D S Su; M Picardo; S Fiorito
Journal:  J Immunol Res       Date:  2014-06-01       Impact factor: 4.818

6.  PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.

Authors:  Artur Świerczek; Elżbieta Wyska; Sebastian Baś; Marta Woyciechowska; Jacek Mlynarski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-20       Impact factor: 3.000

Review 7.  Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis.

Authors:  Chenyang Lei; Juan Jiang; Yanyan Zhang; Gaoyun Xiong
Journal:  J Immunol Res       Date:  2022-03-26       Impact factor: 4.818

8.  Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance.

Authors:  Seon-Yeong Lee; Seung Hoon Lee; Eun-Ji Yang; Eun-Kyung Kim; Jae-Kyung Kim; Dong-Yun Shin; Mi-La Cho
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

9.  Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.

Authors:  Burcu Ayoglu; Anna Häggmark; Mohsen Khademi; Tomas Olsson; Mathias Uhlén; Jochen M Schwenk; Peter Nilsson
Journal:  Mol Cell Proteomics       Date:  2013-06-03       Impact factor: 5.911

10.  Increasing Co-occurrence of Additional Autoimmune Disorders at Diabetes Type 1 Onset Among Children and Adolescents Diagnosed in Years 2010-2018-Single-Center Study.

Authors:  Barbara Głowińska-Olszewska; Maciej Szabłowski; Patrycja Panas; Karolina Żoła Dek; Milena Jamiołkowska-Sztabkowska; Anna Justyna Milewska; Anna Kadłubiska; Agnieszka Polkowska; Włodzimierz Łuczyński; Artur Bossowski
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-06       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.